Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Destiny Pharma Limited - In Liquidation logo — Mark Smith and Stephen Cork were appointed Administrators on...

Destiny Pharma Limited - In Liquidation

Mark Smith and Stephen Cork were appointed Administrators on 21 August 2024, and act without personal liability.

Founded 1997 United Kingdom Brighton, United Kingdom 10 employees Post-IPO Equity Biotechnology, Health Care +1

General Information

Company Name Destiny Pharma Limited - In Liquidation
Founded Year 1997
Location United Kingdom Brighton, United Kingdom
Employees 10
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Destiny Pharma Limited - In Liquidation. To contact Destiny Pharma Limited - In Liquidation, visit destinypharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Destiny Pharma Limited - In Liquidation compare?

A PDF of Destiny Pharma Limited - In Liquidation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Destiny Pharma Limited - In Liquidation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Destiny Pharma Limited - In Liquidation

Destiny Pharma Limited, a United Kingdom-based biotechnology firm founded in 1997, is now In Liquidation under the administration of Mark Smith and Stephen Cork as of 21 August 2024. Despite its innovative pipeline, the company has entered a critical phase of administration owing to its operational circumstances.

The company specializes in the development of groundbreaking medicines aimed at preventing life-threatening infections. Key assets include NTCD-M3, a promising Phase 3 treatment intended to prevent recurrences of C. difficile infection, and XF-73 nasal gel, which concluded a successful Phase 2b trial. Their joint venture aims to develop SPOR-COVTM, targeting COVID-19 prevention.

The last financial boost saw a Post-IPO Equity investment on 16 March 2023. This status indicates potential risks and opportunities for future stakeholders, given its extensive R&D and innovative edge in biotherapeutics.

Business keywords: Clinical Stage Biotechnology, Novel Medicines Development, Microbiome-based Biotherapeutics, C. difficile Infection Prevention, Hospital Acquired Infection Control, Phase 3 Clinical Trials, Post-Surgical Infection Prevention, Staphylococcal Infection Prevention, MRSA Prevention, COVID-19 Prevention, Viral Respiratory Infection Prevention, Antimicrobial Resistance Solutions, Drug-resistant Bacteria Control, SPOR-COVTM Development, XF Drug Series Research

Services & Products

development of anti-infectives
prevention of bacterial infections
clinical trials

Target Customers

hospitals healthcare providers medical professionals biotechnology investors

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed -
16 Mar 2023
Grant Undisclosed -
12 Jul 2022
Grant Undisclosed -
29 Jan 2019
Post IPO Equity Undisclosed -
04 Dec 2017
Venture Series Unknown Undisclosed -
04 Sep 2017
Venture Series Unknown Undisclosed -
04 Aug 2014
Venture Series Unknown Undisclosed -
03 Dec 2008

Destiny Pharma Limited - In Liquidation Alternatives & Competitors

View All Alternatives
Destiny Pharma Limited - In Liquidation vs
LIPUM AB
LIPUM AB Sweden

We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases

Post-IPO Equity
15 employees
Biotechnology, Health Care
Destiny Pharma Limited - In Liquidation vs
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. United States

Discovering solutions for the world

Series B
18 employees
Biopharma, Biotechnology
Destiny Pharma Limited - In Liquidation vs
Redx Pharma
Redx Pharma United Kingdom

Biotech company focusing on the discovery and development of novel targeted medicines to treat cance...

Post-IPO Equity
39 employees
Biotechnology, Health Care
View all alternatives

FAQ About Destiny Pharma Limited - In Liquidation

Mark Smith and Stephen Cork were appointed Administrators on 21 August 2024, and act without personal liability.
Destiny Pharma Limited - In Liquidation was founded in 1997.
Destiny Pharma Limited - In Liquidation is headquartered in Brighton, United Kingdom.
Destiny Pharma Limited - In Liquidation operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Clinical Stage Biotechnology, Novel Medicines Development, Microbiome-based Biotherapeutics and C. difficile Infection Prevention. Its customers include hospitals, healthcare providers and medical professionals.
Destiny Pharma Limited - In Liquidation has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Destiny Pharma Limited - In Liquidation has approximately 10 employees.
Destiny Pharma Limited - In Liquidation has completed 7 funding rounds. The latest funding stage is Post-IPO Equity.
Destiny Pharma Limited - In Liquidation offers: development of anti-infectives, prevention of bacterial infections, clinical trials.
Top alternatives and competitors to Destiny Pharma Limited - In Liquidation include LIPUM AB, Ansun Biopharma, Inc., Redx Pharma, AUROBAC THERAPEUTICS, Avenzo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Destiny Pharma Limited - In Liquidation and LIPUM AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Destiny Pharma Limited - In Liquidation, https://bouncewatch.com/company/destiny-pharma-limited, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes